(2023) Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial. International Immunopharmacology.
Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....
| Item Type: | Article |
|---|---|
| Journal or Publication Title: | International Immunopharmacology |
| Volume: | 115 |
| Publisher: | Elsevier B.V. |
| Depositing User: | ms soheila Bazm |
| URI: | http://eprints.ssu.ac.ir/id/eprint/14548 |
Actions (login required)
 |
View Item |